{"id":61222,"date":"2026-03-27T08:49:56","date_gmt":"2026-03-27T08:49:56","guid":{"rendered":"https:\/\/www.promedical.co.uk\/?p=61222"},"modified":"2026-03-27T08:49:56","modified_gmt":"2026-03-27T08:49:56","slug":"postgraduate-training-is-the-real-bottleneck-and-the-offer-rate-gap-is-widening-fast","status":"publish","type":"post","link":"https:\/\/www.promedical.co.uk\/healthcare-leadership\/postgraduate-training-is-the-real-bottleneck-and-the-offer-rate-gap-is-widening-fast\/","title":{"rendered":"Postgraduate training is the real bottleneck, and the offer rate gap is widening fast"},"content":{"rendered":"<p>The GMC\u2019s Workforce report 2025 makes a blunt point: postgraduate training places have nearly doubled in a decade, but demand has grown too \u2014 and outcomes are diverging sharply by where doctors qualified.<\/p>\n<p>Key takeaways<\/p>\n<ul>\n<li>Non\u2011UK PMQ applications for CT1\/ST1 rose from 5,326 (2018\/19) to 18,857 (2023\/24) \u2014 more than tripling (Part 1, p11).<\/li>\n<li>The proportion of non\u2011UK applicants receiving an offer fell sharply to 23% in 2023\/24 (p11\u201312).<\/li>\n<li>UK graduates\u2019 offer rate also declined over time, but remains far higher: 69% in 2023\/24 (p12\u201313).<\/li>\n<li>Some programmes (notably GP) combine low competition ratios with high non\u2011UK representation, raising questions about how the system allocates opportunity and meets service need (p14).<\/li>\n<\/ul>\n<h3>What\u2019s happening: demand is exploding, supply is constrained<\/h3>\n<p>The report shows a steep rise in non\u2011UK PMQ doctors applying to enter the first year of specialty or core training (CT1\/ST1). The non\u2011UK applicant count more than tripled between 2018\/19 and 2023\/24 (p11).<\/p>\n<p>But offers didn\u2019t rise at the same pace. The result is a collapse in the success rate for non\u2011UK applicants: from a peak where just over half received offers (2019\/20) to under a quarter in 2023\/24 (p11).<\/p>\n<p>Meanwhile, UK graduate applicant numbers have been comparatively stable, and UK offer rates declined more gradually, from a higher starting point (p12\u201313). In 2023\/24, the report highlights the contrast: 23% non\u2011UK vs 69% UK (Foreword p2; p12\u201313).<\/p>\n<h3>Why offer-rate comparisons are powerful \u2014 and also dangerous<\/h3>\n<p>Offer rates are attention-grabbing because they feel like a judgement: \u201cwho is good enough?\u201d<\/p>\n<p>But the report itself cautions indirectly by focusing on offers, not acceptances, and noting doctors may apply to multiple posts (p11; p15). That matters because offer rates can reflect system structure as much as candidate quality.<\/p>\n<p>What offer-rate gaps can reflect (without proving discrimination)<\/p>\n<ul>\n<li>differential access to portfolio-building opportunities<\/li>\n<li>differences in NHS experience or referees<\/li>\n<li>familiarity with UK recruitment norms and scoring<\/li>\n<li>self-selection into more or less competitive programmes<\/li>\n<li>number of programmes applied to (doctors can submit multiple applications)<\/li>\n<\/ul>\n<p>So the right question isn\u2019t \u201cwhy are non\u2011UK doctors worse?\u201d It\u2019s:<br \/>\nWhat does the recruitment system reward, and do all candidates have fair access to those signals?<\/p>\n<p>This is especially important because the UK increasingly relies on doctors who trained abroad \u2014 not just for service posts but for training pipelines that feed future consultant\/GP supply (p14\u201317).<\/p>\n<h3>Programme-level detail: the system isn\u2019t uniform<\/h3>\n<p>The report goes beyond overall offer rates. It shows that in 2023\/24, UK graduates had higher offer proportions across programmes, but the gap varies (p13). In general practice, for example, the report highlights 79% of UK applicants receiving an offer compared with 23% of non\u2011UK applicants (p13).<\/p>\n<p>Then the report adds a second lens: competition ratios and non\u2011UK representation. Some programmes have relatively low competition ratios but high non\u2011UK proportions in the early stages (p14). General practice stands out not because it is uniquely \u201ceasy,\u201d but because it shows how workforce needs, candidate preferences, and programme popularity interact.<\/p>\n<p>The implication is uncomfortable but necessary: some of the programmes the NHS depends on most are becoming disproportionately filled by international doctors.<\/p>\n<p>That\u2019s not a problem in itself \u2014 international doctors are not a \u201cstopgap.\u201d But it becomes a policy risk if leaders attempt to reduce non\u2011UK participation without growing the overall pipeline or addressing why UK graduates apply elsewhere.<\/p>\n<h3>The \u201clocally employed \u2192 training\u201d pipeline is now part of the model<\/h3>\n<p>The report makes an important point that should reshape how we talk about training access: many non\u2011UK doctors apply for specialist training after several years in locally employed (LE) roles (p11; p17). In other words, the system increasingly functions like this:<\/p>\n<ol>\n<li>doctor joins via a route like PLAB<\/li>\n<li>works in LE roles for years<\/li>\n<li>applies into training, often in programmes with lower competition ratios and fewer UK applicants<\/li>\n<\/ol>\n<p>This is not a fringe pathway. It is now a structural feature of how the NHS fills gaps and staffs services.<\/p>\n<p>So if training access becomes less realistic for non\u2011UK doctors, you don\u2019t only affect individuals; you potentially remove a major motivator for doctors to come to the UK at all (p17).<\/p>\n<h3>What should the system do with this insight?<\/h3>\n<p>If your goal is a sustainable workforce, there are three strategic options \u2014 and pretending you can get sustainability without trade-offs is the biggest risk.<\/p>\n<p><strong>Option A: Expand training places further<\/strong><\/p>\n<p>The report shows offers have already grown over the decade (Foreword p2), but demand is outpacing supply. Expanding training numbers is expensive and requires educator capacity \u2014 but it is the most direct way to reduce pressure.<\/p>\n<p><strong>Option B: Improve fairness and transparency of recruitment<\/strong><\/p>\n<p>If outcomes differ sharply by PMQ, leaders should ask:<\/p>\n<ul>\n<li>Are recruitment criteria clear and consistently applied?<\/li>\n<li>Do candidates have equal access to portfolio opportunities and feedback?<\/li>\n<li>Are there avoidable barriers for doctors who didn\u2019t train in the UK?<\/li>\n<\/ul>\n<p>The report\u2019s language about fairness and transparency isn\u2019t limited to employment; it applies to the whole pathway (p10; p17).<\/p>\n<p><strong>Option C: Treat LE and SAS roles as genuine career structures, not waiting rooms<\/strong><\/p>\n<p>Part 2 shows the scale of doctors not on GP\/specialist registers and not in training (p30\u201336). If training is bottlenecked, those doctors still need progression, stability, and development \u2014 otherwise retention suffers.<\/p>\n<h3>The patient impact is the point<\/h3>\n<p>Workforce debates often become tribal: UK vs non\u2011UK. But the report\u2019s underlying message is pragmatic: the NHS is already dependent on international doctors, and policy choices must consider service delivery reality (Foreword p3; p14\u201317).<\/p>\n<p>A training system that becomes a dead end for large numbers of doctors will not just frustrate careers; it will weaken retention, reduce future supply, and raise the risk of rota fragility.<\/p>\n<p>In workforce planning, bottlenecks are never neutral. They push pressure elsewhere \u2014 usually onto patients, supervisors, and overstretched teams.<\/p>\n<p><em><strong>Source: GMC Workforce Report 2025<\/strong><\/em><\/p>\n","protected":false},"excerpt":{"rendered":"<p>The GMC\u2019s Workforce report 2025 makes a blunt point: postgraduate training places have nearly doubled in a decade, but demand has grown too \u2014 and outcomes are diverging sharply by where doctors qualified. Key takeaways Non\u2011UK PMQ applications for CT1\/ST1 rose from 5,326 (2018\/19) to 18,857 (2023\/24) \u2014 more than tripling (Part 1, p11). The&hellip;<\/p>\n","protected":false},"author":26,"featured_media":61226,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_seopress_robots_primary_cat":"none","footnotes":""},"categories":[25],"tags":[],"class_list":["post-61222","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-healthcare-leadership"],"acf":[],"_links":{"self":[{"href":"https:\/\/www.promedical.co.uk\/af-api\/wp\/v2\/posts\/61222","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.promedical.co.uk\/af-api\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.promedical.co.uk\/af-api\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.promedical.co.uk\/af-api\/wp\/v2\/users\/26"}],"replies":[{"embeddable":true,"href":"https:\/\/www.promedical.co.uk\/af-api\/wp\/v2\/comments?post=61222"}],"version-history":[{"count":1,"href":"https:\/\/www.promedical.co.uk\/af-api\/wp\/v2\/posts\/61222\/revisions"}],"predecessor-version":[{"id":61225,"href":"https:\/\/www.promedical.co.uk\/af-api\/wp\/v2\/posts\/61222\/revisions\/61225"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.promedical.co.uk\/af-api\/wp\/v2\/media\/61226"}],"wp:attachment":[{"href":"https:\/\/www.promedical.co.uk\/af-api\/wp\/v2\/media?parent=61222"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.promedical.co.uk\/af-api\/wp\/v2\/categories?post=61222"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.promedical.co.uk\/af-api\/wp\/v2\/tags?post=61222"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}